Reference
Rattanawong W, Anukoolwittaya P, Hiransuthikul A, Pongpitakmetha T, Trisataya A, Thanprasertsuk S, et al. Medication underuse in real-life practice: The impact of galcanezumab towards achieving very low frequency episodic migraine in a Southeast Asian middle-income nation. The Journal of Headache and Pain. 2025 Jan 16;26(1). doi:10.1186/s10194-025-01952-1